Cheng Deng Increases ZEPP Holdings with Recent Stock Purchase
ZEPP's CFO Cheng Deng made notable stock transactions on June 26, 2026.
Key Points
- On June 26, 2026, Cheng Deng, CFO of ZEPP, bought 22,875 shares, while ZEPP's stock traded at $4.49.
- Several institutional investors like FIL LTD and Morgan Stanley increased their holdings in ZEPP, with notable share additions.
- Citi maintained its 'buy' rating for ZEPP with a target price of $3.10 as of August 21, 2023.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Cheng Deng, the Chief Financial Officer of ZEPP, made significant stock transactions on June 26, 2026. He purchased 22,875 shares, adding to his position in the company. ZEPP's stock traded at $4.49 on Monday, providing an opportunity for insiders to adjust their holdings.
Insider Buying and Selling at Zepp Health Corporation
On June 26, 2026, Cheng Deng, ZEPP's CFO, was active in the market. He bought 22,875 shares and sold 9,836 shares on the same day. Earlier, on April 1, 2026, he also purchased 366,000 shares. These transactions were not part of a pre-planned trading program, indicating personal investment decisions.
Other Institutional Activity in ZEPP
Several institutional investors have shown interest in ZEPP recently. FIL LTD increased its holdings by 91,596 shares, bringing its total to 717,352 shares valued at approximately $8.57 million, marking a 14.6% increase. Morgan Stanley also grew its position by 97,397 shares, reaching 707,691 shares worth about $8.46 million, representing a 16% increase. Meanwhile, Point72 Asset Management slightly reduced its stake by 294 shares, now holding 577,676 shares valued at $6.90 million. Millennium Management trimmed its holdings by 24,322 shares, resulting in a 6.6% decrease, ending with 342,504 shares valued at $4.09 million. Monolith Management LTD notably increased its position by 40,182 shares, a 30.1% rise, totaling 173,847 shares worth $2.08 million.
Analysts Set New Price Targets
Citi maintained its 'buy' rating for ZEPP, setting a price target of $3.10 on August 21, 2023. This reflects confidence in the company's future prospects despite current market conditions.
Bottom Line
Cheng Deng's recent stock transactions in ZEPP highlight his confidence in the company's future. Institutional investors have also been actively adjusting their positions, signaling interest in ZEPP. While insider activities and analyst ratings provide insights, it's important to remember that these are backward-looking indicators and may not reflect current market conditions.
Get Zepp Health Corporation alerts
New 13F filings, insider trades, and analyst moves on $ZEPP, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.